EBP1 potentiates amyloid β pathology by regulating γ-secretase

Kim BS
January 8, 2025
Nat Aging
https://pubmed.ncbi.nlm.nih.gov/39779912

This article is currently being updated. View its version on PubMed.

https://pubmed.ncbi.nlm.nih.gov/39779912

Research summary

This study investigates the role of EBP1 in modulating amyloid β (Aβ) pathology through regulation of γ-secretase. Loss of EBP1 increases Aβ production and deposition, while its restoration ameliorates cognitive impairments and reduces amyloid burden.

Key outcome of the study

EBP1 negatively regulates γ-secretase activity. Its loss leads to increased Aβ production, plaque accumulation, and cognitive decline. Restoring EBP1 improves amyloid clearance and behavioral outcomes.

Mouse model

Conditional EBP1 Knockout mouse model generated by genOway, targeting the Pa2g4 gene. The model includes a reporter gene coupled via IRES and allows for Cre-dependent inactivation of EBP1 in specific tissues.

TARGET:
Pa2g4
EBP1

Keywords

Alzheimer's disease, Amyloid β, γ-secretase, Neurodegeneration, Cognitive function

Technical specifications

Conditional Knockout mouse model, IRES-reporter, Cre-lox system, Forebrain-specific targeting, AAV delivery, Behavioral testing

Related products

Catalogue product

No items found.

Customized product

Time-dependent KO mouse

Use an inducible conditional Knockout mouse to age-dependently inactivate your gene, and to enable studies at defined development stages or on age-related diseases.